SCHEMBL3430834

SCHEMBL3430834

O=C(Nc1[c]nccc1)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.57
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MGLL Q99685 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 2/20 0.46
TSHR P16473 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
LMNA P02545 2/20 0.46
NAMPT P43490 1/20 0.45
ROCK2 O75116 1/20 0.45
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3425959 0.81 NPC1 (0.46) POLBNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL2035775 0.78 NPC1 (0.54) POLBNPC1RAB9AMGLLSMN1; SMN2
SCHEMBL3719682 0.77 POLB (0.54) POLBNPC1RAB9AMGLLSMN1; SMN2
SCHEMBL27924561 0.75 MGLL (0.52) POLBNPC1RAB9AMGLLSMN1; SMN2
SCHEMBL9195782 0.75 TDP1 (0.54) POLBRAB9AALDH1A1TSHRCYP3A4
SCHEMBL7360148 0.74 MGLL (0.51) POLBNPC1RAB9AMGLLSMN1; SMN2
SCHEMBL7229196 0.74 NPC1 (0.61) POLBNPC1RAB9AMGLLSMN1; SMN2
SCHEMBL18640773 0.74 POLB (0.65) POLBNPC1RAB9AMGLLSMN1; SMN2
SCHEMBL27330799 0.73 MGLL (0.50) POLBNPC1RAB9AMGLLSMN1; SMN2
Benzyl Phenylcarbamate SCHEMBL1222943 0.73 POLB (0.78) POLBNPC1RAB9AMGLLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010146351-A1 INDOLYLMETHYL-MORPHOLINE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2010-12-23 WO disclosed
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 POLB 4097/4885NPC1 812/4885RAB9A 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.